Tag: BNT162b2
Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India
US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus ... Read More
Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company ... Read More
Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine
BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their ... Read More
Pfizer, BioNTech get Canadian approval for BNT162b2 Covid-19 vaccine
US pharma giant Pfizer and German biotech company BioNTech have bagged Health Canada approval for their BNT162b2 Covid-19 vaccine. The BNT162b2 vaccine has been authorized ... Read More
UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization ... Read More
BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech
Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in ... Read More
Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada
Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate against SARS-CoV2, depending on clinical success and ... Read More
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech
Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine ... Read More
BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status
Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More